Images List Premium Download Classic

G Protein

G Protein-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Processing reagent and use thereof in assays for detection of analytes associated with a binding ...
Quidel Corporation
October 12, 2017 - N°20170292964

Methods for preparing a sample for detection of an analyte of interest that is bound in vivo to a protein are provided. The method comprises providing a processing reagent comprising metaperiodate and contacting a sample suspected of comprising an analyte of interest associated with a protein with the processing reagent to form a mixture. The analyte of interest, if present ...
Modified proteins and methods of making and using same
Life Technologies Corporation
October 12, 2017 - N°20170292156

Methods, compositions, systems, apparatuses and kits comprising modified proteins, particularly modified nucleic acid-binding proteins with altered buffering properties are provided. For example, in some embodiments, methods of forming modified proteins including one or more amino acid modifications to achieve desired pka values are described. Furthermore, the invention provides methods for using such modified proteins in ion-producing reactions, such as ion-based ...
Genetically expanded cell free protein synthesis systems, methods and kits
B.g Negev Technologies And Applications Ltd., At Ben-gurion University
October 12, 2017 - N°20170292139

This invention relates to methods of producing a rare amino acid- or non-natural amino acid-containing protein in a cell free protein synthesis system and kits for use in and for accomplishing same. Specifically, the methods comprise the steps of expressing at least one orthogonal suppressor trna (o-trna)/aminoacyl-trna synthetase (aars) pair or derivatives thereof specific for incorporation of a rare ...
G Protein Patent Pack
Download 625+ patent application PDFs
G Protein Patent Applications
Download 625+ G Protein-related PDFs
For professional research & prior art discovery
inventor
  • 625+ full patent PDF documents of G Protein-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method of forming microparticles for use in cell seeding
The Brigham And Women`s Hospital, Inc.
October 12, 2017 - N°20170292109

The present invention is directed to methods for forming microparticles useful for cell seeding and for conjugating protein to the surface of the microparticles. The method comprises co-injecting an organic solution of plga or other polymer with an aqueous solution into a flow focusing tube.
Modulation of stimulatory and non-stimulatory myeloid cells
The Regents Of The University Of California
October 12, 2017 - N°20170291946

Provided herein are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e. G., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an antigen binding protein such as an antibody or antigen binding fragment thereof.
Method for purifying protein
Sysmex Corporation
October 12, 2017 - N°20170291918

Disclosed is a method for purifying a protein, comprising steps of: preparing a sample containing a fusion protein containing an amino acid sequence of a peptide tag and an amino acid sequence of a target protein; and separating contaminant proteins contained with the fusion protein in the sample and the fusion protein in the sample, wherein the peptide tag contains 12 ...
G Protein Patent Pack
Download 625+ patent application PDFs
G Protein Patent Applications
Download 625+ G Protein-related PDFs
For professional research & prior art discovery
inventor
  • 625+ full patent PDF documents of G Protein-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Compositions and methods for long acting proteins
Novartis Ag
October 12, 2017 - N°20170290876

The present invention is based, in part, on the discovery of peptide tags that increase the half-life and/or mean residence time of proteins or nucleic acids in the eye. In certain aspects the invention peptide tags increase the half-life and/or mean residence time of antibodies and antigen binding fragments, therapeutic proteins, protein receptors, darpins and/or aptamers in ...
Necrosis inhibitors
National Institute Of Biological Sciences, Beijing
October 12, 2017 - N°20170290790

The invention provides amides that inhibit cellular necrosis and/or human receptor interacting protein 1 kinase (rip1), including corresponding sulfonamides, and pharmaceutically acceptable salts, hydrides and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant ...
Compositions comprising recombinant bacillus cells and an insecticide
Spogen Biotech Inc.
October 12, 2017 - N°20170290339

The present invention relates to a composition comprising a) recombinant exosporium-producing bacillus cells that express a fusion protein comprising: (i) at least one plant growth stimulating protein or peptide and (ii) a targeting sequence that localizes the fusion protein to the exosporium of the bacillus cells; and b) at least one particular insecticide disclosed herein in a synergistically effective amount. ...
Method for calculating feed value of alfalfa hay using information available at time of baling
Spogen Biotech Inc.
October 05, 2017 - N°20170284988

A method where the weight of the bale is measured by a scale on the baler, the moisture of the bale is measured by sensors on the baler and this information is sent to a processor. Based on compaction properties of the leaf verses the stem of the alfalfa, the processor calculates a feeding value for the hay including protein, ...
Methods to improve plant-based food and feed
Plant Sensory Systems, Llc.
October 05, 2017 - N°20170283821

The present invention describes an alternative approach to increase taurine (tau) or methionine (met) production in eukaryotes, namely by the insertion of components of a sulfur-metabolic pathway and tau- or met-binding proteins in organisms where the peptides do not exist or have not clearly been identified. The invention describes methods for the use of polynucleotides that encode functional cysteine dioxygenase (...
Antigen binding proteins that bind c-met
Sorrento Therapeutics Inc.
October 05, 2017 - N°20170283501

There is disclosed compositions and methods relating to or derived from anti-c-met antibodies. More specifically, there is disclosed fully human antibodies that bind c-met, c-met-binding fragments and derivatives of such antibodies, and c-met-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making ...
Compositions comprising recombinant bacillus cells and another biological control agent
Spogen Biotech Inc.
October 05, 2017 - N°20170283472

The present invention relates to a composition comprising a) recombinant exosporium-producing bacillus cells that express a fusion protein comprising: (i) at least one plant growth stimulating protein or peptide and (ii) a targeting sequence that localizes the fusion protein to the exosporium of the bacillus cells; and b) at least one further biological control agent selected from particular microorganisms disclosed ...
G Protein Patent Pack
Download 625+ patent application PDFs
G Protein Patent Applications
Download 625+ G Protein-related PDFs
For professional research & prior art discovery
inventor
  • 625+ full patent PDF documents of G Protein-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Protein labeling with cyanobenzothiazole conjugates
Promega Corporation
October 05, 2017 - N°20170283456

The invention provides compounds and methods for site-specifically labeling proteins with cyanobenzothiazole derivatives of formula i. For example, the invention provides methods for labeling the n-terminus of a protein that terminates with a cysteine residue. The invention also provides methods for isolating an n-terminally labeled protein and methods for detecting an n-terminally labeled protein.
Pyrimido-diazepinone compounds and methods of treating disorders
Dana-farber Cancer Institute, Inc.
October 05, 2017 - N°20170283422

The present invention relates to novel pyrimido-diazepinone compounds, methods of modulating protein kinases, including mps1 (ttk), erk5 (bmk1, mapk7), lrkk2, epha2, polo kinase 1, 2, 3, or 4, ack1, ack2, abl, dcamkl1, abl1, abl mutants, dcamkl2, ark5, brk, mknk2, fgfr4, tnk1, plk1, ulk2, plk4, prkd1, prkd2, prkd3, ros1, rps6ka6, taok1, taok3, tnk2, bcr-abl, gak, csrc, tpr-met, tie2, met, fgfr3, aurora, axl, bmx, btk, ...
Protein-protein interaction inducing technology
Arvinas, Inc.
October 05, 2017 - N°20170281784

The present disclosure is based on the surprising and unexpected discovery that a ligand molecule with certain characteristics is able to bind to two protein molecules simultaneously and recruit them to form a transient or stable protein-protein interaction complex. The protein-protein interaction and other cross-domain interactions gained in this process contribute additional stabilization energy to the complex beyond the combination ...
Antigen binding proteins that bind pd-l1
Sorrento Therapeutics, Inc.
October 05, 2017 - N°20170281765

There is disclosed compositions and methods relating to or derived from anti-pd-l1 antibodies. More specifically, there is disclosed fully human antibodies that bind pd-l1, pd-l1-binding fragments and derivatives of such antibodies, and pd-l1-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods ...
Activin type 2 receptor binding proteins and uses thereof
Adimab, Llc
October 05, 2017 - N°20170281711

This disclosure provides actrii-binding proteins such as anti-actriia and anti-actriib antibodies, and compositions and methods for making the actrii-binding proteins. In certain aspects the actrii-binding proteins inhibit, or antagonize actrii activity. In addition, the disclosure provides compositions and methods for diagnosing and treating diseases and conditions associated muscle wasting; a fibrotic condition; an inflammatory, cardiovascular, pulmonary, musculoskeletal, neurologic, ocular, skeletal, ...
Single molecule peptide sequencing
Board Of Regents, The University Of Texas System
September 28, 2017 - N°20170276686

The present invention relates to the field of identifying proteins and peptides, and more specifically large-scale sequencing of single peptides in a mixture of diverse peptides at the single molecule level. The present invention also relates to methods for identifying amino acids in peptides, including peptides comprising unnatural amino acids. In one embodiment, the present invention contemplates labeling the n-terminal ...
Cell-free assay device and methods of use
Electronic Bio Sciences, Inc.
September 28, 2017 - N°20170276678

Provided herein is a cell-free assay device, sometimes comprising a lipid bilayer and an endopeptidase assay component, for characterizing a pore forming protein. In some embodiments provided herein is an apparatus comprising a pressure system for characterizing an interaction. Also, provided herein are methods for using a cell-free assay device to characterize a pore forming protein and/or a test ...
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (...
Amgen Inc.
September 28, 2017 - N°20170275370

Methods of treating metabolic diseases and disorders using an antigen binding protein specific for the gipr polypeptide are provided. In various embodiments the metabolic disease or disorder is type 2 diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels and diabetic nephropathy. In certain embodiments the antigen binding protein is administered in combination with a glp-1 receptor agonist.
Loading